Psychopharmacology of ADHD:
children and adolescents

by
Findling RL, Dogin JW
Department of Psychiatry,
Case Western Reserve University,
School of Medicine,
Cleveland, Ohio, USA.
J Clin Psychiatry 1998; 59 Suppl 7:42-9


ABSTRACT

Medications can provide significant salutary effects for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Due to their well-established safety and efficacy, psychostimulants are generally considered first-line pharmacotherapy for most young patients with ADHD. Since psychostimulant treatment often requires frequent dosing and may be associated with unacceptable side effects and risks, other classes of medication have been studied as possible treatment alternatives. The most extensively researched nonstimulant medications are the tricyclic antidepressants. In addition, alpha2 agonists have also been shown to reduce symptoms of ADHD. However, concerns regarding potential cardiotoxicity have tempered the enthusiasm for both of these classes of medication. Newer antidepressants such as bupropion and venlafaxine may hold promise as treatments for ADHD.
ADHD
Adderall
Overdose
Pregnancy
Precursors
Stereotypies
Neurotoxicity
VTA/glutamate
CNS stimulants
Self-medication
AD/HD: new drugs
Genetics and AD/HD
Appetite suppressants
Methamphetamine psychosis
Methamphetamine/narcolepsy
Amphetamine withdrawal/depression
AD/HD: alternatives to psychostimulants



Refs
and further reading

amphetamines.com
HOME
HedWeb
Nootropics
Cocaine.org
Cannabis.net
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhappiness?
Utopian Surgery?
The Good Drug Guide
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World